Ubs Asset Management Americas Inc Jazz Pharmaceuticals PLC Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 189,220 shares of JAZZ stock, worth $26.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
189,220
Previous 174,078
8.7%
Holding current value
$26.3 Million
Previous $19.4 Million
20.1%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding JAZZ
# of Institutions
543Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$853 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$838 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$351 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$307 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$282 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.7B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...